PROMETHEUS BIOSCIENCES, INC. Proceeds from Issuance Initial Public Offering
PROMETHEUS BIOSCIENCES, INC. reported Proceeds from Issuance Initial Public Offering of $218.50 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2023-02-28
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance initial public offering for the quarter ending 2021-12-31 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance initial public offering for the quarter ending 2021-09-30 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance initial public offering for the quarter ending 2021-06-30 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance initial public offering for the quarter ending 2021-03-31 was $218.50M.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance initial public offering for fiscal 2021 was $218.50M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $218.50M 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $218.50M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $218.50M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $218.50M 10-Q · filed 2022-05-12 |